圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02257 圣诺医药-B

未开盘 10-08 16:08:48

15.460

-0.090

-0.58%

最高15.750	最低14.870	成交量39.75万
今开15.550	昨收15.550	日振幅5.66%
总市值16.23亿	流通市值16.23亿	总股本1.05亿
成交额606.29万	换手率0.38%	流通股本1.05亿
市净率-40.76	ROE-1188.81%	每股收益-5.16
52周最高22.780	52周最低2.350	市盈率-3.00
股息0.00	股息收益率0.00	ROA-39.84%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02257","market":"HK","secType":"STK","nameCN":"圣诺医药-B","latestPrice":15.46,"timestamp":1759910928033,"preClose":15.55,"halted":0,"volume":397450,"delay":0,"floatShares":105000000,"shares":105000000,"eps":-5.161667885881492,"marketStatus":"未开盘","change":-0.09,"latestTime":"10-08 16:08:48","open":15.55,"high":15.75,"low":14.87,"amount":6062885,"amplitude":0.056592,"askPrice":15.46,"askSize":400,"bidPrice":15.4,"bidSize":1400,"shortable":0,"etf":0,"ttmEps":-1.2637939890115022,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759973400000},"marketStatusCode":0,"adr":0,"listingDate":1640793600000,"exchange":"SEHK","adjPreClose":15.55,"openAndCloseTimeList":[[1759887000000,1759896000000],[1759899600000,1759910400000]],"volumeRatio":0.7106653988620532,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02257","defaultTab":"news","newsList":[{"id":"2573498090","title":"圣诺医药-B盘中异动 下午盘股价大涨5.50%报15.720港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573498090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573498090?lang=zh_cn&edition=full","pubTime":"2025-10-06 14:07","pubTimestamp":1759730826,"startTime":"0","endTime":"0","summary":"2025年10月06日下午盘14时07分，圣诺医药-B股票出现波动，股价急速上涨5.50%。截至发稿，该股报15.720港元/股，成交量68.58万股，换手率0.65%，振幅10.07%。资金方面，该股资金流入666.964万港元，流出323.877万港元。圣诺医药-B股票所在的生物技术行业中，整体跌幅为0.92%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100614070694bc7473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100614070694bc7473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2571361843","title":"圣诺医药-B盘中异动 下午盘股价大涨5.12%报15.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571361843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571361843?lang=zh_cn&edition=full","pubTime":"2025-09-29 13:52","pubTimestamp":1759125131,"startTime":"0","endTime":"0","summary":"2025年09月29日下午盘13时52分，圣诺医药-B股票出现异动，股价大幅拉升5.12%。截至发稿，该股报15.200港元/股，成交量36.01万股，换手率0.34%，振幅7.19%。资金方面，该股资金流入218.781万港元，流出273.056万港元。圣诺医药-B股票所在的生物技术行业中，整体涨幅为1.02%。其主要临床候选药物包括STP705和STP707。交易完成后，华熙生物将持有圣诺医药9.44%的股权，跃升为第二大股东。华熙生物此次对圣诺医药的战略投资，背后折射出公司所面临的现实增长压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092913521297b03bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092913521297b03bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2570788229","title":"圣诺医药-B09月26日主力净流出93.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2570788229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570788229?lang=zh_cn&edition=full","pubTime":"2025-09-26 16:16","pubTimestamp":1758874561,"startTime":"0","endTime":"0","summary":"09月26日, 圣诺医药-B股价跌0.34%，报收14.46元，成交金额594.2万元，换手率0.39%，振幅4.89%，量比0.68。圣诺医药-B今日主力资金净流出93.9万元，上一交易日主力净流入28.4万元。该股近5个交易日下跌11.67%，主力资金累计净流出129.1万元；近20日主力资金累计净流入1998.0万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926162208a445728a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926162208a445728a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2568476591","title":"圣诺医药-B09月18日获主力加仓104.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568476591","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568476591?lang=zh_cn&edition=full","pubTime":"2025-09-18 16:15","pubTimestamp":1758183332,"startTime":"0","endTime":"0","summary":"09月18日, 圣诺医药-B股价涨1.80%，报收17.00元，成交金额1031.6万元，换手率0.59%，振幅9.76%，量比0.34。圣诺医药-B今日主力资金净流入104.1万元，连续7日净流入，上一交易日主力净流入154.9万元。该股近5个交易日下跌11.82%，主力资金累计净流入1446.3万元；近20日主力资金累计净流入2004.9万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918161834a4cd535e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918161834a4cd535e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":1},{"id":"2567191335","title":"圣诺医药-B盘中异动 股价大跌5.21%报18.730港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567191335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567191335?lang=zh_cn&edition=full","pubTime":"2025-09-15 15:13","pubTimestamp":1757920421,"startTime":"0","endTime":"0","summary":"2025年09月15日下午盘15时13分，圣诺医药-B股票出现异动，股价急速跳水5.21%。截至发稿，该股报18.730港元/股，成交量141.265万股，换手率1.34%，振幅9.16%。资金方面，该股资金流入1106.83万港元，流出1523.08万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。圣诺医药-B股票所在的生物技术行业中，整体涨幅为5.25%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509151513419792e647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509151513419792e647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2567158194","title":"医药行业：继续看好创新药械产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2567158194","media":"国泰海通证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567158194?lang=zh_cn&edition=full","pubTime":"2025-09-14 00:00","pubTimestamp":1757779200,"startTime":"0","endTime":"0","summary":"持续推荐创新 药械及产业链。2025 年9 月第二周A 股医药板块表现弱于大盘。2025 年9 月第二周上证综指上涨1.5%，SW 医药生物下跌0.4%，涨跌幅在申万一级行业中排名第26 位。生物医药板块中表现相对较好的细分板块医疗器械、医药商业、医疗服务。截至2025 年9 月12 日，医药板块相对于全部A 股的溢价水平目前处于正常水平，当前相对溢价率82.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509141526389790e397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509141526389790e397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1141","BK1576","03692","BK1161","01530","BK1583","03347"],"gpt_icon":0},{"id":"2566763106","title":"迈博药业-B盘中异动 下午盘快速拉升6.41%报0.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566763106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566763106?lang=zh_cn&edition=full","pubTime":"2025-09-10 13:30","pubTimestamp":1757482248,"startTime":"0","endTime":"0","summary":"2025年09月10日下午盘13时30分，迈博药业-B股票出现波动，股价快速上涨6.41%。截至发稿，该股报0.830港元/股，成交量36.2万股，换手率0.01%，振幅10.26%。资金方面，该股资金流入1660港元，流出27.652万港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.02%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091013304895203c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091013304895203c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574","02617","06628","02257"],"gpt_icon":0},{"id":"2566710621","title":"医美龙头押注“核酸药物第一股” 跨界布局藏何深意？","url":"https://stock-news.laohu8.com/highlight/detail?id=2566710621","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566710621?lang=zh_cn&edition=full","pubTime":"2025-09-10 12:53","pubTimestamp":1757479990,"startTime":"0","endTime":"0","summary":"【医美龙头押注“核酸药物第一股” 跨界布局藏何深意？】9月10日早间开盘一小时内，圣诺医药（02257.HK）股价上涨7.18%至22.1港元/股。回溯近期股价表现，圣诺医药9月8日涨幅达22.78%，报18.38港元/股收盘；9月9日股价再次上涨12.19%，最终以20.62港元/股收盘。在这背后，一则融资公告或成关键推手。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509103509764835.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509103509764835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02257","BK4567","ASO","BK4200","BCC","BK4561","BK4104","BK1161"],"gpt_icon":0},{"id":"2566626885","title":"圣诺医药-B盘中涨超9% 本年内股价累计涨幅已超530%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566626885","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566626885?lang=zh_cn&edition=full","pubTime":"2025-09-10 11:04","pubTimestamp":1757473440,"startTime":"0","endTime":"0","summary":"　　圣诺医药-B盘中涨超9%，本年内累计涨幅已超530%，截至发稿，股价上涨7.27%，现报22.12港元，成交额3301.62万港元。　　圣诺医药近日宣布，向华熙生物科技（香港）等四名投资者折让19.84%配售合共1735.24万股新股份。华熙生物表示，此次通过旗下全资子公司斥资约1.38亿元，认购圣诺医药战略配售的股份，完成配售后公司将持股圣诺医药约9.44%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-09-10/doc-infpyprr9628820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2566462308","title":"港股异动 | 圣诺医药-B(02257.HK)再涨超9% 华熙生物认购公司超9%股份 加码小核酸医美赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2566462308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566462308?lang=zh_cn&edition=full","pubTime":"2025-09-10 10:30","pubTimestamp":1757471458,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5aaec95b07afdce68b3c101ed62a5f7d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","02257","BK0229","688363","BK1161"],"gpt_icon":0},{"id":"2566669353","title":"华熙生物豪掷万金入股圣诺医药，加码创新药与定向减脂赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2566669353","media":"动脉网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566669353?lang=zh_cn&edition=full","pubTime":"2025-09-09 16:36","pubTimestamp":1757406960,"startTime":"0","endTime":"0","summary":"华熙生物通过全资子公司以每股12港元的价格认购圣诺医药1735.24万股新股，总投资约1.38亿港元，持股比例达9.44%，成为其战略投资者。双方将重点推进STP705靶向减脂项目等siRNA医学美容管线的研发与商业化。STP705目前处于三期临床阶段，是全球首个在siRNA治疗癌症领域内达到积极临床II期结果的药物，在治疗皮肤基底细胞癌的II期临床试验中效果显著，且已启动多个适应症的临床试验，并获得孤儿药资格。siRNA利用RNA干扰技术调控特定基因表达。此外，文章还提及了小核酸固相合成载体及核酸药物纯化填料的供应信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909170528951e6c4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909170528951e6c4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1574","06978","BK1161"],"gpt_icon":0},{"id":"2566693556","title":"圣诺医药融资2.08亿港币；燃石医学第二季度亏损970万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566693556","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566693556?lang=zh_cn&edition=full","pubTime":"2025-09-09 13:06","pubTimestamp":1757394393,"startTime":"0","endTime":"0","summary":"9月8日，圣诺医药公告表示，日前与机构签订认购协议，将以12港币价格，融资2.08亿港币。截止6月末，公司现金及现金等价物不足5000万元。财报显示，公司第二季度实现营收1.49亿元人民币，同比增长10%，环比增长12%；毛利率提升至72.8%，较去年同期的70.4%增长2.4%；净亏损从去年同期的1.08亿元人民币收窄至970万元人民币。2）燃石医学第二季度亏损970万元9月8日，燃石医学发布了2025年第二季度业绩公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909131224a718780b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909131224a718780b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2566665256","title":"医保基金监管细则公开征求意见发布；第一三共新生产大楼开工","url":"https://stock-news.laohu8.com/highlight/detail?id=2566665256","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566665256?lang=zh_cn&edition=full","pubTime":"2025-09-09 10:05","pubTimestamp":1757383554,"startTime":"0","endTime":"0","summary":"政策动向《中药生产监督管理专门规定》发布9月8日，国家药监局公布《中药生产监督管理专门规定》（以下简称《规定》），自2026年3月1日起施行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509093508530127.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509093508530127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","ADC","BK4097","BK4231","02257","OS","BK4080"],"gpt_icon":0},{"id":"2566066651","title":"港股异动 | 圣诺医药-B(02257.HK)再涨超12% 公司获华熙生物战略股权投资 双方将探讨业务层面合作可能性","url":"https://stock-news.laohu8.com/highlight/detail?id=2566066651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566066651?lang=zh_cn&edition=full","pubTime":"2025-09-09 09:44","pubTimestamp":1757382296,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","688363","BK0239","02257","BK0229"],"gpt_icon":0},{"id":"2565977508","title":"圣诺医药-B(02257.HK)涨幅扩大逾18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565977508","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565977508?lang=zh_cn&edition=full","pubTime":"2025-09-08 13:58","pubTimestamp":1757311110,"startTime":"0","endTime":"0","summary":"每经AI快讯，圣诺医药-B(02257.HK)涨幅扩大逾18%，月内累计涨幅已超90%。截至发稿，涨18.84%，报17.79港元，成交额4530.42万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509083507506775.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509083507506775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"1168738881","title":"圣诺医药-B宣布Bloomage Biotech进行战略股权投资，共同推进下一代生命科学管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1168738881","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168738881?lang=zh_cn&edition=full","pubTime":"2025-09-08 12:17","pubTimestamp":1757305034,"startTime":"0","endTime":"0","summary":"圣诺医药-B宣布Bloomage Biotech进行战略股权投资，共同推进下一代生命科学管线","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2565057940","title":"圣诺医药折让19.84%配股筹逾2亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565057940","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565057940?lang=zh_cn&edition=full","pubTime":"2025-09-08 10:18","pubTimestamp":1757297907,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02257","688363","BK0239","BK0229","BK1161"],"gpt_icon":0},{"id":"2565767875","title":"港股异动 | 圣诺医药-B(02257.HK)涨超10% 拟折让约19.84%发行1735.24万股认购股份 净筹约2.06亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565767875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565767875?lang=zh_cn&edition=full","pubTime":"2025-09-08 09:38","pubTimestamp":1757295488,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"94a36d9e9ad684c6a1c23071984751f8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"1167440547","title":"港股生物医药股延续强势！映恩生物-B涨近12%，宜明昂科-B涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167440547","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167440547?lang=zh_cn&edition=full","pubTime":"2025-09-08 09:37","pubTimestamp":1757295467,"startTime":"0","endTime":"0","summary":"9月8日，港股$生物(000504)$医药股延续强势，$映恩生物-B(09606)$涨近12%，$宜明昂科-B(01541)$涨超11%，$圣诺医药-B(02257)$、$荃信生物-B(02509)$涨近10%，$复宏汉霖(02696)$涨超8%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2ea7ccd6a31b3cd6d3ea988a9ba76c8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","02257","01541"],"gpt_icon":0},{"id":"2565348520","title":"圣诺医药-B(02257)拟折让约19.84%发行1735.24万股 净筹约2.06亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565348520","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565348520?lang=zh_cn&edition=full","pubTime":"2025-09-08 06:23","pubTimestamp":1757283794,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣诺医药-B(02257)发布公告，于2025年9月7日，公司拟向该等认购人(华熙生物科技(香港)有限公司、谢硕豪先生、Bamboo Bloom Limited、Capstone Resources Holding Limited)发行1735.24万股认购股份，相当于经配发及发行所有认购股份扩大的本公司已发行股本约14.16%。认购价为每股认购股份12.00港元，较9月5日收市价每股14.97港元折让约19.84%。认购事项所得款项总额将约为2.082亿港元。认购事项所得款项净额将约为2.06亿港元。集团拟将认购事项所得款项用作其一般营运资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.sirnaomics.com/en/","stockEarnings":[{"period":"1week","weight":0.0225},{"period":"1month","weight":-0.1589},{"period":"3month","weight":1.7607},{"period":"6month","weight":4.0195},{"period":"1year","weight":2.7074},{"period":"ytd","weight":3.4682}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1166},{"period":"6month","weight":0.2828},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.3375}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Sirnaomics Ltd是一家投资控股公司。该公司及其子公司是临床阶段的生物技术公司，从事核糖核酸干扰（RNAi）技术和多种疗法的开发和商业化。该公司致力于发现和开发针对该地区未满足医疗需求的适应症的药物。其主要临床候选药物包括STP705和STP707。其STP705是一种用于治疗非黑色素瘤皮肤癌 (NMSC) 的无菌药物产品，包括原位鳞状细胞癌和基底细胞癌 (BCC)、瘢痕疙瘩切除术后复发的瘢痕疙瘩、肥厚性瘢痕 (HTS) 和实体肝肿瘤，以及 用于医学美容。其STP707是一种无菌药物产品，用于治疗实体瘤，包括肝癌、转移性皮肤鳞状细胞皮肤癌 (cSCC) 和非小细胞肺癌。其正在利用其双重交付平台，其中包括多肽纳米颗粒 (PNP) 和GalAhead。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166818},{"month":2,"riseRate":0.75,"avgChangeRate":-0.005191},{"month":3,"riseRate":0.25,"avgChangeRate":-0.121551},{"month":4,"riseRate":0.25,"avgChangeRate":-0.056034},{"month":5,"riseRate":0.5,"avgChangeRate":0.03445},{"month":6,"riseRate":0.75,"avgChangeRate":-0.008205},{"month":7,"riseRate":0.75,"avgChangeRate":0.15893},{"month":8,"riseRate":0.25,"avgChangeRate":-0.085891},{"month":9,"riseRate":0.75,"avgChangeRate":0.238751},{"month":10,"riseRate":0.25,"avgChangeRate":-0.087818},{"month":11,"riseRate":0,"avgChangeRate":-0.053191},{"month":12,"riseRate":0.666667,"avgChangeRate":0.031361}],"exchange":"SEHK","name":"圣诺医药-B","nameEN":"SIRNAOMICS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺医药-B,02257,圣诺医药-B股票,圣诺医药-B股票老虎,圣诺医药-B股票老虎国际,圣诺医药-B行情,圣诺医药-B股票行情,圣诺医药-B股价,圣诺医药-B股市,圣诺医药-B股票价格,圣诺医药-B股票交易,圣诺医药-B股票购买,圣诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}